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Abstract
Background: GBS, MEWS, and PER scoring systems are not commonly used for patients presenting to emergency
department with GIS bleeding. This study aimed to determine the value of MEWS, GBS, and PER scores in
predicting bleeding at follow-up, endoscopic therapy and blood transfusion need, mortality, and rebleeding
within a 1-month period.
Methods: A total of 202 consecutive patients with upper GIS bleeding between July 2013 and November 2014
were prospectively enrolled in the study. The relationship between MEWS, GBS, and PER scores and hospital
outcome, bleeding at follow-up, endoscopic therapy, transfusion need, rebleeding, and death were examined.
Results: The study included a total of 202 subjects, with 84 (41.6 %) females and 118 (58.4 %) males. There was a
significant correlation between GBS, MEWS, and PER scores and hospital outcomes (p <0.004, p <0.001, p <0.001,
respectively). A GBS score greater than 11 succesfully predicted bleeding at follow-up (p = 0.0237). GBS score's
sensitivity for predicting endoscopic therapy was greater than those of other scoring systems. The discriminatory
power of each scoring system was significant for predicting transfusion (p <0.0001, p = 0.0470, and p = 0.0014,
respectively). A GBS score greater than 13, a MEWS score greater than 2, and a PER score greater than 3 predicted
death. A PER score greater than 3 predicted rebleeding (p <0.0001).
Conclusion: The scoring systems in question can be easily calculated in patients presenting to ED with upper GIS
bleeding and may be beneficial for risk stratification, determination of transfusion need, prediction of rebleeding,
and decisions of hospitalization or discharge.
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Background
Acute upper gastrointestinal system (GIS) bleeding is a
common and life-threatening condition [1]. It origi-
nates proximal to the ligament of Treitz and forms
85 % of all GIS bleeding episodes [2, 3]. It is associated
with an annual incidence of 50–172/100.000, a mortality of
2–15 %, and a rebleeding rate around 10–30 % [4]. The
approach to upper GIS bleeding consists of maintenance
of hemodynamic stability and determination of the amount
and localization of bleeding [5]. The prognosis of GIS
bleeding is variable, from mild to life-threatening bleeding
[6]. As in all life-threatening conditions in an emergency
department (ED), physical examination, diagnostic proce-
dures, and therapeutic efforts should be simultaneously
initiated, and patients should be resuscitated and stabilized
in upper GIS bleeding [5].
In patients with upper GIS bleeding a triage system for
decisions regarding emergency vs delayed endoscopy
may shorten hospital stay and cut costs, although this is
not always the case. Thus, triage and scoring systems
together may categorize patients into low-risk and high-
risk groups based on admission criteria prior to endoscopy
and may prove more practical [2]. Risk scores based on
clinical and endoscopic variables have been developed for
patients with acute GIS bleeding [7]. These scoring sys-
tems are the widely used Glasgow Blatchford score (GBS)
and Rockall scoring systems. Rockall is a scoring system
with pre-endoscopic rockall (PER) and endoscopic com-
ponents. GBS is a scoring system using basic clinical and
laboratory variables [2, 8]. Modified early warning score
(MEWS) is a simple, physiological, bedside scoring sys-
tem. It may help recognize critical or potentially critical
patients [9, 10].
Risk stratification in upper GIS bleeding has been a
topic of research in the last couple of years [11]. Contra-
versy surrounds risk stratification, role of endoscopic
therapy, and indications for medical and surgical treat-
ment. There is, therefore, no consensus on a specific ap-
proach to such patients [2]. Early recognition and accurate
risk stratification of patients with higher mortality and
rebleeding risks may increase the efficiency of patient care
while providing guidance for emergency physicians for
making final decisions (hospital admission, intensive care
unit admission, discharge from ED) [12, 13]. This study
aimed to determine the efficiency of GBS, MEWS and
PER scores in predicting bleeding at follow-up, need for
endoscopic therapy (endoscopic intervention requirement
for homeostasis) and blood transfusion, mortality, and
rebleeding within 1 month.
Methods
Study design
This study was prospectively conducted in patients pre-
senting to the ED of Mersin University Faculty of
Medicine with upper GIS bleeding between July 2013
and November 2014. The study was approved by the
local ethics committee of Mersin University (Dated 11
July 2013, No: 2013/229). Before starting the study, we
carried out a power analysis. A review of medical re-
cords yielded 600 patients meeting inclusion criteria
who presented to the ED between 1 January 2012 and
31 December 2012 and who were diagnosed with the
disorder in question. It is considered that the number of
patients presenting to the ED for a time period of 1 year
from 15 July 2013 would reach at least that number.
Under the light of this information, reaching at least
30 % of the population would suffice to best represent
the population [14]. According to the power analysis,
we intended to enroll 180 patients with upper GIS
bleeding for this study. The criteria of inclusion were
patients over the age 18 who presented to ED with
melena, hematochesia, and hematemesis and who were
confirmed to have upper GIS bleeding by esophagogas-
troduodonoscopy (EGD) (Fujinon, JAPAN). Patients re-
ferred by another institution after initial treatment,
those who did not undergo EGD, those whose bleeding
was not of upper GIS origin, and those who could not
be followed within the first month after discharge were
excluded. In addition, pregnant and trauma patients
were also excluded. All patients presenting to ED with
upper GIS bleeding received an consisting of proton
pump inhibitors, fluid resuscitation, and securing air-
way and breathing. Age, sex, presenting complaint
(hematochesia, hematemesis, melena, syncope, active
bleeding), rectal examination findings, type and amount
of transfusion if any, endoscopy findings, endoscopic
and surgical interventions, bleeding at follow-up, hos-
pital outcome (discharge from ED, hospitalization,
death), and rebleeding within 1 month after admission
were recorded in pre-prepared data forms. A total of
202 consecutive patients with upper GIS bleeding were
prospectively enrolled in the study. ED staff and endos-
copists not were aware of the study.
GBS, MEWS and PER scores were calculated according
to clinical and laboratory data, as described in the original
articles [4, 8, 10] (Tables 1 and 2). The correlation of these
scores to hospital outcome, bleeding at follow-up, need
for endoscopic therapy (endoscopic intervention require-
ment for homeostasis), transfusion need, rebleeding, and
death was examined.
Bleeding at follow-up was defined as recurrent hema-
temesis, coffee ground vomitus or hemodynamic in-
stability coupled with ongoing melena or hematocrit
drop. Rebleeding is defined as hematemesis, coffee
ground vomitus, or melena, blood in feces, and admis-
sion to hospital for this reason within a 1-month period
after discharge from ED or hospital ward. Death was de-
fined as loss of life in ED or hospital ward. Endoscopic
Bozkurt et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine  (2015) 23:109 Page 2 of 9
therapy was defined as isotonic saline, epinephrine
(1 mg, 1/1000, Biopharma, Turkey) or sclerosing agent
injection (sclerotherapy) (aethoxysklerol ampul %1,
Kreussler pharma, German) electrocoagulation (Erbe,
German), clips (Olympus, Japan) and band ligation
(Boston scientific, USA) applications. Blood transfu-
sions were used in patients with a hemoglobin level
below 10 g/dl and hemodynamic instability despite
fluid resuscitation [15].
Statistical analysis
The statistical analyses were performed with the MedCalc,
v15.4. Demo version (MedCalc Software, Ostend, Belgium,
http://www.medcalc.be/). Normality of the continuous
variables was tested using Shapiro Wilk test. Student t test
was used to test the differences in mean age by gender.
The differences between GBS, MEWS, and PER scores
with respect to regular ward or intensive care admission
were analyzed with Mann Whitney U test while their
differences with regard to hospital outcome were tested
using Kruskal Wallis test. Paired comparisons of these
parameters was performed with Mann Whitney U test.
Descriptive statistics were presented as mean and standard
deviation for normally distributed variables and minimum,
maximum, median, and 25–75 % percentiles for non-
normally distributed variables. Receiver operator charac-
teristic (ROC) curve analysis were made for GBS, MEWS
and PER scores for bleeding, endoscopic treatment,
necessary of blood transfusion and recurrent bleeding
within a month and the comparision of these scores.
Each parameter was classified according to the cut off
values that measured. According to the calculated cut-off
value was reclassified each parameter. As the descriptive
statistics, receiver operating characteristic curve (AUC),
sensitivity, specifity, positive predictive value (PPV), nega-
tive predictive value (NPV), likelihood ratio (LR) + and
LR- values and 95 % confidence intervals (CI) were pro-
vided. A p value of less than 0.05 was considered statis-
tically significant.
Results
Demographic and clinical data
The annual number of patients presenting to the ED of
our hospital was 65,160, of which 0.22 % were the upper
GIS bleeding cases. During the study period (July 2013
and November 2014) a total of 97,754 patients were
admitted to our ED, of whom 219 suspected with upper
GIS bleeding. Two patients refused endoscopy, 7 had
non-upper GIS bleeding, 8 were lost to follow-up by
1 month and all of them were excluded from the study.
The study included a total of 202 subjects, with 84
(41.6 %) females and 118 (58.4 %) males. The mean age
of the study population was 61.1 ± 17.3 years. The mean
age of the female and male subjects were 63.3 ± 18.7 and
59.6 ± 16.2 years, respectively and no differences be-
tween the sex had been observed (p = 0.127). Variceal
hemorrhages constitute 29.2 % of the bleeding events.
Hematemesis and melena were the admission symptoms
Table 1 Glasgow-Blatchford score, pre-endoscopic rockall score,
modified early warning score
Glasgow-Blatchford score
Admission risk marker Score component value
Blood urea nitrogen (mg/dL)
≥ 18.2 <22.4 mg/dL 2
≥ 22.4 <28 mg/dL 3
≥ 28 <70 mg/dL 4
≥ 70 mg/dL 6
Hemoglobin for men (g/dL)
≥ 12 <13 g/dL 1
≥ 10 <12 g/dL 3
<10 g/dL 6
Hemoglobin for women (g/dL)
≥ 10 <12 g/dL 1
<10 g/dL 6
Systolic blood pressure
≥ 100 <109 mm Hg 1
≥ 90 <99 mm H 2
<90 mm Hg 3
Other markers
Pulse ≥100/min 1
Presentation with melena 1










No shock: SBP ≥100, pulse <100 0
Tachycardia: SBP ≥100, pulse ≥100 1
Hypotension: SBP <100 2
Comorbidity
No major comorbidity 0
Cardiac failure, ischemic heart
disease, any major comorbidity
2
Renal failure, liver failure,
disseminated malignancy
3
SBP systolic blood pressure
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in 47.5 and 45 % of patients, respectively. Rectal examin-
ation revealed melena in 61.9 % of these patients. Of the
patients with upper GIS bleeding, 52.7 % underwent
sclerotherapy, 74.8 % were admitted to hospital, and 12.6 %
of the patients had rebleeding within 1 month after dis-
charge (Table 3).
Scores and patient outcomes
GBS, MEWS, and PER scores were significantly cor-
related to hospital outcomes (p = 0.004, p <0.001, and
p <0.001, respectively). The median GBS score was
significantly greater in the hospitalized patients than
the discharged ones (p <0.001) and in the non-surviving
patients than the discharged ones (p = 0.001). The non-
surviving patients had a significantly greater median
MEWS score compared to the discharged and hospitalized
ones (p = 0.001 and p = 0.003, respectively). The median
PER score was significantly greater in both hospitalized
and non-surviving patients compared to the discharged
ones (p = 0.002 and p <0.001). Furthermore, median PER
score of the non-surviving patients was significantly greater
than the hospitalized patients (p = 0.007) (Table 4).
ROC curve analyses of the scores and the parameters
ROC curve analyses for continuous variables regarding
bleeding at follow-up revealed that only the GBS score's
predictive ability was statistically significant, with a GBS
score greater than 11 predicted bleeding at follow-up
(p = 0.0237). MEWS and PER scores greater than 4 pre-
dicted bleeding at follow-up, although they did not
reach statistical significance (p = 1.000 and p = 0.055).
MEWS had a greater specifity (94.1 %) for bleeding at
follow-up than the other two scores (Table 5, Fig. 1a).
ROC curve analyses in patients that underwent endo-
scopic therapy showed that patients with a GBS score
greater 5, a MEWS score greater than 1, and a PER score
greater than 3 needed an endoscopic examination. GBS,
MEWS and PER scores had very low discriminative
abilities for prediction of need of endoscopic therapy
(AUC: 0.51, 0.51 and 0.58, respectively) (Table 5, Fig. 1b).
Analysis of ROC curves of the continuous variables in
transfused patients showed that all three scoring systems
were significantly able to predict transfusion (p <0.0001,
Table 3 Demographical and clinical data of the patients that
are included in the study
Data Number Percent
Gender Female 84 41.6
Male 118 58.4






Active bleedinga 6 3.0
RT finding Melena 125 61.9
No Melena 57 28.2
Rectum empty 12 5.9
Hematochezia 8 4.0
Endoscopic treatment Sclerotherapy 29 52.7
Adrenalin injection 2 3.6
Band ligation 20 36.4
Other 4 7.3
Bleeding type Varicous 59 29.2
Non varicous 143 70.8
Hospital outcome Discharge 40 19.8
Hospitalization 151 74.8
Death 11 5.4
One month later result Normal 158 82.7
Rebleeding 24 12.6
Death 9 4.7
Hospitalization place Service 112 69.1
Intensive care unit 50 30.9
Blood transfusion Applied 146 72.3
Not applied 56 27.7
Bleeding at follow-up Bleeding 34 16.8
Not bleeding 168 83.2
aActive bleeding, fresh red gushing bleeding from mouth and rectum
Table 2 Glasgow-Blatchford score, pre-endoscopic rockall score, modified early warning score
Modified early warning score
Score 3 2 1 0 1 2 3
SBP mmHg <70 71–80 81–100 101–199 – >200 –
Heart rate, bpm – <40 41–50 51–100 101–110 111–129 >130
Respiratory rate, rpm – <9 – 9–14 15–20 21–29 >30
Temperature, 1C – <35 – 35.0–38.4 – >38.5 –
AVPU – – – A V P U
AVPU: A alert, V reacting to voice, P reacting to pain, U unresponsive
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p = 0.0470, and p = 0.0014, respectively). According to
the analysis, a GBS score greater than 10, a MEWS score
greater than 1, and a PER score greater than 3 predicted
transfusion need. The values of GBS were higher than
those of the other two scoring systems. GBS was signifi-
cantly more effective than the other two scoring systems
in predicting transfusion need (p <0.0001 vs each of the
other two systems) (Table 5, Fig. 1c).
In patients who died after upper GIS bleeding the
ROC curve analysis of continuous variables demon-
strated that the three scores were significantly able to
predict death (p = 0.0222, p <0.0001, and p <0.0001). A
GBS score greater than 13, a MEWS score greater than 2,
and a PER score greater than 3 predicted death. PER score
had a greater sensitivity (90.9 %) and NPV (99 %) com-
pared to other two scores (Table 5, Fig. 1d).
ROC curve analysis demonstrated that a PER score
greater than 3 significantly predicted rebleeding for dis-
charged patients within 1 month and it was statistically
significant (p <0.0001). PER score had a sensitivity of
95.8 %, specifity of 60.5 %, and NPV of 99.2 %. A cut-off
level of 2 for MEWS and 12 for GBS predicted rebleed-
ing, although their discriminatory ability was not statisti-
cally significant (p = 0.0638 and p = 0.073, respectively).
PER score had a greater NPV (99.2 %) compared to
other two scores. PER score predicted rebleeding within
1 month significantly better than GBS and MEWS scores
(PER and GBS p = 0.0055 and PER and MEWS p <0.0001)
(Table 5, Fig. 1e).
Discussion
Many risk stratification tools are used in clinical prac-
tice, especially for critically-ill patients. Emergency phy-
sicians need some tools for making decisions between a
safe early discharge with outpatient follow-up and endo-
scopic examination and follow-up in ED. In patients
admitted to ED with the complaint of GIS bleeding, it is
not clear which scoring system must be used or what
the efficacy of these systems are. We investigated the
ability of GBS, MEWS, and PER scores for predicting
bleeding at follow-up, need for endoscopic therapy,
transfusion need, death, and rebleeding. Our study dem-
onstrated that GBS and PER scores were significantly
lower in discharged patients compared to admitted pa-
tients. However, MEWS scores of the discharged and ad-
mitted patients were similar. This can be explained by a
slight increase in pulse and respiratory rates of patients
at the early stages of bleeding. A recent study suggested
that GBS accurately predicted outcomes including need
for intensive care [16]. Hence, scoring systems can pro-
vide valuable information concerning the urgency of en-
doscopy and level of patient care (i.e., whether patient
care and follow-up should be made in regular ward or
intensive care unit). Our study demonstrated signifi-
cantly different efficacy in determining ward or intensive
care admission. In non-surviving patients MEWS and
PER scores were significantly greater than admitted pa-
tients whereas no such difference existed for GBS. Subbe
et al. reported that death and intensive care unit admis-
sion were more frequent in cases with a MEWS score
greater than 5 compared to those with a MEWS score
less than 5 [17]. In our study MEWS score was signifi-
cantly greater in non-surviving patients compared to
other patients. Another result of our study was that hos-
pitalized and non-surviving patients had no difference
with respect to GBS score. GBS is not developed for pre-
dicting mortality [18]. This may be explained by the ab-
sence of prominent blood urea elevation in early stages of
upper GIS bleeding, or lack of hemoglobin drop due to
hemoconcentration in patients with blood loss. In study
with GIS bleeding, Conflicting results have been reported
regarding the role of age in mortality [6, 19, 20].










1–18 12 [10–14] 1–8 2 [1–3] 0–7 3 [2–4]
Intensive care
unit (n = 50)
6–17 13 [10.75–15.00] 1–9 2.5 [2–4] 0–6 5 [3–5]
p 0.004 0.004 <0.001
Hospital outcome Dischargea
(n = 40)
2–18 9 [5–12] 1–5 2 [1–3] 0–6 2 [0.25–4.00]
Hospitalization
(n = 151)
1–18 12b [10–14] 1–8 2 [1–3] 0–7 3b [2–5]
Death (n = 11) 9–17 14b [11–15] 2–9 4b,c [2–5] 3–6 5b,c [4–5]
p 0.004 <0.001 <0.001
Abbreviations: GBS Glasgow Blatchford score, MEWS modified early warning score, PER pre-endoscopic rockall
aDischarge containing the patients discharged from the emergancy service. bShows differance between discharge; cshows differance between hospitalizing
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Table 5 The ROC analysis results of the continuous variables
Cut off AUC (p value) Sensitivity [95 % CI] Specifity [95 % CI] PPV [95 % CI] NPV [95 % CI] LR+ [95 % CI] LR- [95 % CI]
Bleeding at follow-up GBS >11 0.613 (0.0237) 70.59 [52.5–84.9] 51.19 [43.4–59.0] 22.64 [15.1–31.8] 89.58 [81.7–94.9] 1.45 [1.1–1.9] 0.57 [0.3–1.0]
MEWS >4 0.500 (1.000) 14.71 [5.0–31.1] 94.05 [89.3–97.1] 33.33 [11.8–61.6] 84.49 [78.5–89.4] 2.47 [0.9–6.8] 0.91 [0.8–1.0]
PER >4 0.600 (0.0550) 44.12 [27.2–61.1] 76.19 [69.0–82.4] 27.27 [16.1–41.0] 87.07 [80.6–92.0] 1.85 [1.2–3.0] 0.73 [0.5–1.0]
Endoscopic therapy GBS >5 0.514 (0.7501) 94.64 [85.1–98.9] 10.49 [6–16.7] 29.28 [22.8–36.5] 83.33 [58.6–96.4] 1.06 [1–1.1] 0.51 [0.2–1.7]
MEWS >1 0.508 (0.8623) 33.93 [21.8–47.8] 71.33 [63.2–78.6] 31.67 [20.3–45.0] 73.38 [65.2–80.5] 1.18 [0.8–1.9] 0.93 [0.7–1.1]
PER >3 0.577 (0.0769) 57.14 [43.2–70.3] 54.55 [46.0–62.9] 32.99 [23.8–43.3] 76.47 [67.0–84.3] 1.26 [0.9–1.7] 0.79 [0.6–1.1]
Need for blood transfusion GBS >10 0.829 (<0.0001) 79.45 [72.0–85.7] 76.79 [63.6–87.0] 89.92 [83.4–94.5] 58.90 [46.8–70.39 3.42 [2.1–5.6] 0.27 [0.2–0.4]
MEWS >1 0.584 (0.0470) 73.29 [65.3–80.3] 39.29 [26.5–53.2] 75.89 [68.0–82.7] 36.07 [24.2–49.4] 1.21 [1.0–1.5] 0.68 [0.4–1.0]
PER >3 0.642 (0.0014) 55.48 [47.0–63.7] 67.86 [54.0–79.7] 81.82 [72.8–88.9] 36.89 [27.6–47.0] 1.73 [1.1–2.6] 0.66 [0.5–0.8]
Death GBS >13 0.679 (0.0222) 63.64 [30.8–89.1] 72.77 [65.9–79.0] 11.86 [4.9–22.9] 97.20 [93.0–99.2] 2.34 [1.4–3.9] 0.50 [0.2–1.1]
MEWS >2 0.772 (<0.0001) 72.73 [39.0–94.0] 65.45 [58.2–72.2] 10.81 [4.8–20.2] 97.66 [93.3–99.5] 2.10 [1.4–3.2] 0.42 [0.2–1.1]
PER >3 0.767 (<0.0001) 90.91 [58.7–99.8] 53.40 [46.1–60.6] 10.10 [5.0–17.8] 99.03 [94.7–100.0] 1.95 [1.5–2.5] 0.17 [0.03–1.1]
Rebleeding GBS >12 0.663 (0.0073) 70.83 [48.9–87.4] 65.27 [57.5–72.5] 22.67 [13.8–33.8] 93.97 [88.0–97.5] 2.04 [1.5–2.8] 0.45 [0.2–0.8]
MEWS >2 0.617 (0.0638) 50.0 [29.1–70.9] 67.66 [60.0–74.7] 18.18 [9.8–29.6] 90.40 [83.8–94.9] 1.55 [1.0–2.4] 0.74 [0.5–1.1]
PER >3 0.832 (<0.0001) 95.83 [78.9–99.9] 60.48 [52.6–67.9] 25.84 [17.1–36.2] 99.02 [94.7–100.0] 2.42 [2.0–3.0] 0.07 [0.01–0.5]
the “Bold numbers” p<0.05. Abbreviations: GBS Glasgow Blatchford score, MEWS Modified early warning score, PER pre-endoscopic rockall, ROC receiver operator characteristic, AUC receiver operating characteristic curve,

















Although we did not explored the effect of age on mor-
tality, the difference between the median PER scores
suggests that age may be a factor in mortality.
Most GIS bleeds improve without blood transfusions,
endoscopic therapy, or surgical intervention [20]. Its has
been shown by many studies that GBS performs better
than Rockall score in predicting adverse events including
death, blood transfusion, endoscopic therapy, and sur-
gery in patients with upper GIS bleeding [12, 18, 21].
Studies exploring the value of GBS and PER scores in
predicting need for endoscopic therapy, transfusion
need, rebleeding, and mortality in upper GIS bleeding
have been usually performed on the basis of low risk
(score = 0) and high risk (score > 0) [8, 22–24]. One of
the striking results of our study was that none of the
three scoring systems revealed zero points. This indi-
cates that patients with upper GIS bleeding admitted to
tertiary centers like ours are more risky and require
more careful management. GBS's sensitivity and specifity
for prediction of rebleeding has been reported as 100
and 25 % while they have been reported as 90.2 and
38 % for PER [23]. GBS reportedly predicted the need
for endoscopic therapy better than PER [24]. It has been
reported that GBS and PER scores had a high sensitivity
(100 and 95 %) but a low specifity (4 %, 9 %) [7]. Dicu et
al. found no difference between GBS and PER scores for
predicting bleeding at follow-up [25]. Our study reveales
that GBS alone significantly predicted bleeding at
follow-up for scores greater than 11. However, in line
with the study of Dicu, ROC curves for bleeding at
follow-up produced no difference between GBS and PER
scores. For bleeding at follow-up, GBS had a sensitivity
of 70.6 %, specifity of 51.2 %, a PPV of 22.6 %, and a
NPV of 89.6 %.
GBS can reliably predict need for endoscopic therapy,
and need for clinical and surgical intervention [18, 21, 25].
Two studies from the United Kingdom reported that the
ROC curve for determining need for clinical intervention
remained below 0.92 [6] and 0.90 [26] in about 16 % of
low-risk patients. A Japanese study similarly reported an
area under curve of 0.63 [27]. We determined that GBS
had a greater sensitivity than other scores for predicting
the need for endoscopic therapy. In contrast to former
studies, however, areas under curve of GBS and PER
scores were similar. GBS, MEWS, and PER scores had a
sensitivity of 94.6, 33.9, and 57.2 %, respectively; a
Fig. 1 a–e. The comparison of ROC analysis of GBS, MEWS and PER scores. Bleeding at follow-up (a), endoscopic therapy (b), blood transfusion
(c), mortality (d), 30 days- rebleeding (e), the predicting sensitivity and specificity of scores
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specifity of 10.5, 71.3, and 57.1 %, respectively; a PPV
of 29.3, 31.7, and 33 %, respectively; and a NPV of 83.3,
73.8, and 76.5 %, respectively.
Studies exploring the ability of the scores for pre-
dicting transfusion need revealed that GBS had a
better predictive ability than PER [18, 21, 25]. Our
study determined that GBS performed better than both
MEWS and PER for prediction of transfusion need. The
sensitivity (79.5 %), specifity (76.8 %), PPV (76.8 %), and
NPV (58.9 %) of GBS were greater than those of the
other two scores. GBS is a scoring system that con-
siders hemoglobin level, systolic blood pressure and
pulse rate of the patients. For that reason it is assumed
to better predict the need of transfusion.
Stanley and colleagues reported that GBS and PER
scores may predict death with similar accuracy [21].
Subbe et al. found a higher death and intensive care unit
admission rate in patients with a MEWS score greater
than 5 compared to those with a score less than 5 [17].
Our study demonstrated that MEWS scores greater than
a cutoff value of 2 can predict death. In addition, all
three scores could pedict death with no significant dif-
ferences between their areas under curve. PER score had
a greater sensitivity (90.9 %) and NPV (99 %) than other
scores for mortality prediction. GBS is superior to PER
score in prediction of low-risk patients [20]. Our study
also indicated that rebleeding might occur within a 1-
month period with a PER score greater than 3 and it
was statistically significant. The sensitivity of PER for
rebleeding was 95.8 %, specifity 60.5 %, and NPV
99.2 %. It was determined that rebleeding may be
predicted, albeit statistically non-signifiacantly, by a
MEWS cutoff level of 2 and the cutoff levels deter-
mined for GBS.
Limitations
There are some limitations of the present study. First, it
was a single-center, low-volume study. Nevertheless,
most critical patients are referred to our department
since our hospital is a university hospital providing ter-
tiary care service. However, multi-center, high-volume
studies may still be conducted. Second, blood transfu-
sion need is not a parameter for determination of
endoscopy need. The indication for endoscopy and clinical
condition were taken into account only. Decisions about
endoscopic examination were made by gastroenterologists
and with appropriate criteria. Inter-individual differences
may still exist, however.
Conclusion
GBS was found to be better with respect to prediction of
transfusion need and PER score was found to be better
in prediction of re-bleeding during the 1-month follow-
up period. In conclusion it was observed that none of
these current scoring systems are solely superior than
the other and in fact they are complimentary to each
other. It was seen that there is no single efficient scoring
system in clinical practice and they all have some su-
perior and inferior properties.
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